-
CONITEC in Action: A Trend Analysis of CONITEC’s Evaluation Outcomes From 2020 to Present Day
Sep 9, 2025, 16:22 PM -
Cross-Agency Analysis of Six-Minute Walk Test (6MWT) Adoption in Muscular and Nonmuscular Neurological HTA Submissions: Assessing Surrogate Endpoints for Disease Progression
Sep 9, 2025, 16:22 PM -
Work Complexity in Adults With Phenylketonuria in Sweden in 2020
Sep 9, 2025, 16:22 PM -
Quantifying the Economic Impact of Flexible Endoscope-Related Procedure Rescheduling in NHS Endoscopy Services: A Retrospective Analysis and Survey-Based Model
Sep 9, 2025, 16:22 PM -
Shared Decision Making in Inflammatory Bowel Disease: An Observational Study Combining Patient Physician and Observer Perspectives
Sep 9, 2025, 16:22 PM -
What Makes a Medicine Innovative? A Literature Review of Evaluation Frameworks
Sep 9, 2025, 16:22 PM -
Model Behavior: A Health Economics Checklist for Sales Models
Sep 9, 2025, 16:22 PM -
Comparing Clinical Benefit Criteria in Health Technology Assessment of Oncology Drugs in the Netherlands and Europe: Driving Real Value or Inequal Access?
Sep 9, 2025, 16:22 PM -
Using a Large Language Model (LLM) for Data Extraction of Studies: Learnings From a Targeted Literature Review (TLR) in Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Lung-Cancer Diagnostic Trajectories: A Nationwide Process-Mining Cluster Analysis of 18,569 French Patients
Sep 9, 2025, 16:22 PM -
Budget Impact of Nivolumab Plus Ipilimumab Plus Chemotherapy as First-Line Treatment for Patients With Metastatic Non-Small Cell Lung Cancer in Switzerland
Sep 9, 2025, 16:22 PM -
Using Social Media Listening to Understand Oncology-Specific Patient Experiences: A Comparison of Pharmaceutical Industry-Funded vs. Nonpharmaceutical Industry-Funded Studies
Sep 9, 2025, 16:22 PM -
Clinical Outcome Assessments in Drug Approvals: Trends and Insights From FDA; EMA Labeling 2018-2023
Sep 9, 2025, 16:22 PM -
Comparator Misalignment As a Contributor to Negative Reimbursement Decisions for Pharmaceuticals in Sweden
Sep 9, 2025, 16:22 PM -
Gaps in Cancer Screening Uptake in Ireland: Trends, Barriers and Policy Implications
Sep 9, 2025, 16:22 PM -
KRAS Alterations in Advanced Non-Small Cell Lung Cancer (NSCLC): Temporal Trends in Testing Patterns and Targeted Treatment Use Across Europe Between 2018 and 2024
Sep 9, 2025, 16:22 PM -
Global Payer Policies Potentially Impacting Pharma Pricing and Market Access Strategies: A Review of Five Key Trends Shaping Pharma Future
Sep 9, 2025, 16:22 PM -
Assessing Patient Access to Psoriasis Treatments in Central, South, and Eastern European Countries: Insights and Disparities?
Sep 9, 2025, 16:22 PM -
Valuing Health States When Transitioning From Stage 2 to Stage 3 Type 1 Diabetes in a Sample of the General Population in the United Kingdom
Sep 9, 2025, 16:22 PM -
Semaglutide in Transition: A Nationwide Register-Based Study in Finland 2019-2024
Sep 9, 2025, 16:22 PM
